1277864

Long Grove Pharmaceuticals LLC — FEI 3015940282

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 9, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Rosemont, IL (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)